Lobaric Acid Synthesis via Ullmann Coupling and Grignard Reaction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for synthesizing lobaric acid and its analogues, such as lobarin, lobastin, methyllobarin, and sakisacaulon A, are not economically efficient and lack simplicity, hindering their widespread use as selective inhibitors of PTP1B, a protein tyrosine phosphatase involved in antidiabetic and other therapeutic applications.

Innovation Solution

A method involving coupling reactions and deprotection steps is developed to synthesize lobaric acid and its analogues, utilizing compounds like 4-halogen phthalic anhydride and 2,4-dihydroxybenzoic acid, with specific steps including Ullmann coupling, Grignard reactions, and ortho-iodination, to achieve high yields and economic production.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If conventional extraction and isolation methods are used to obtain lobaric acid and analogues from lichen sources, then the natural compounds can be obtained with authentic structures, but the production cost is high and the yield is low

Engineering Contradiction:
Improvestructural authenticityVSAvoidproduction yield
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The synthesis is divided into multiple discrete steps including Ullmann coupling to form the ether bond, Grignard reaction to introduce the hydroxyl group, and selective oxidation to form the final depsidone structure. Each step is optimized independently to maintain high overall yield while ensuring structural authenticity through controlled reaction conditions

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Protecting groups are strategically introduced before key coupling reactions to prevent side reactions and ensure high selectivity. The preliminary protection of phenolic hydroxyl groups as methyl ethers allows the Ullmann coupling to proceed cleanly, followed by deprotection to reveal the authentic natural product structure

Inventive Principle:
Principle #10Preliminary action

2Reliability

If conventional extraction methods are used from lichen sources, then natural compounds are obtained, but the synthesis process is complex and economically inefficient

Engineering Contradiction:
Improvenatural source authenticityVSAvoidsynthesis process complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

Simpler commercial intermediles such as 3,4-dihydroxybenzoic acid and 2-hydroxy-3-methoxybenzaldehyde are used as starting materials instead of complex natural extraction processes. These readily available intermediates streamline the synthesis while maintaining the ability to produce authentic lobaric acid and analogues through controlled chemical transformations

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The synthesis employs parameter optimization including temperature control during Ullmann coupling, stoichiometry control in Grignard reactions, and selective oxidation conditions to achieve high yields. These parameter optimizations simplify the overall process by reducing purification steps and minimizing side products, making the synthesis economically efficient while maintaining reliability

Inventive Principle:
Principle #35Parameter changes

3Adaptability or versatility

If existing synthesis methods are used for lobaric acid analogues, then some analogues can be produced, but the methods lack simplicity and economic efficiency

Engineering Contradiction:
Improveanalogue synthesis capabilityVSAvoidsynthesis simplicity
Core Design Contradiction:
Adaptability or versatilityVSEase of manufacture

Solution Approach 1:

The synthetic route is designed to be universally applicable to multiple lobaric acid analogues by varying only the substituents on the benzene rings. The core Ullmann coupling and Grignard reaction sequence remains the same, allowing easy adaptation to produce lobastin, methyllobarin, sakisacaulon A, and other analogues from different commercial starting materials, thereby achieving both versatility and simplicity

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

Commercial intermediates with pre-installed substituents (methyl groups, hydroxyl groups, halogens) are used as starting materials. This preliminary functionalization allows the final coupling steps to proceed directly to the desired analogues without additional complex transformations, enhancing both ease of manufacture and adaptability across different analogue structures

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method allows for the simple and economic synthesis of lobaric acid and its analogues with high yield, enabling their effective use as selective PTP1B inhibitors, potentially addressing various therapeutic needs including antidiabetic effects.

Implementation Method 1

a coupling reaction with a compound of Formula 16 or 21

Methodology Applied
Scientific EffectUllmann coupling: Chemical Bonding

Implementation Method 2

utilizing compounds like 4-halogen phthalic anhydride and 2,4-dihydroxybenzoic acid, with specific steps including Ullmann coupling, Grignard reactions

Methodology Applied
Scientific EffectGrignard reaction: Chemical Bonding

Implementation Method 3

specific steps including Ullmann coupling, Grignard reactions, and ortho-iodination

Methodology Applied
Scientific Effectortho-iodination: Chemical Bonding

Data Source

PatentEP3733656B1Method for synthesis of lobaric acid and analog thereof
Publication Date: 2023.05.10 KOREA INSTITUTE OF OCEAN SCIENCE & TECHNOLOGY
  • EP3733656B1 patent drawingFigure 1
  • EP3733656B1 patent drawingFigure 2
  • EP3733656B1 patent drawingFigure 3

AI summary

The present invention can synthesize lobaric acid and four analogues thereof, which are five phenolic lichen metabolites isolated from an extract of the Antarctic lichen Stereocaulon alpinum and selectively inhibit PTP1B, by a simple, economic and efficient chemical synthesis method.